gentian violet has been researched along with naringenin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Chen, H; Gao, Z; Lin, C; Lin, H; Lin, Y; Liu, H; Liu, SL; Luo, L; Luo, Y; Shi, Y; Wang, P; Wang, W; Xie, K; Yang, H; Yang, J; Zeng, Z; Zhao, Y | 1 |
1 other study(ies) available for gentian violet and naringenin
| Article | Year |
|---|---|
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; DNA, Ribosomal; ErbB Receptors; Female; Flavanones; Gastrointestinal Microbiome; Gentian Violet; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases | 2022 |